Login
$LBRX
$42.99 -$0.02 (0.05%) Live

Company Executives

Officer Age In this role 2025 pay Source
Heather Turner Also a director
President & Chief Executive Officer and Director
53 Not stated $11,884,985
Joseph M. Miller
Chief Financial Officer
Title from the Form 4 dated Oct 9, 2026
Not stated Not stated Not reported
Kaya Pai Panandiker
Chief Commercial Officer
49 Since 2025
1 year
Not reported
Susan G. Kozauer
Chief Medical Officer
Title from the Form 4 dated Oct 9, 2026
Not stated Not stated Not reported
Marc Panoff
Senior Vice President, Finance
55 Since 2024
2 years
Not reported
Richard Silva
Senior Vice President, Technical Operations
58 Since 2025
1 year
Not reported
Gad Soffer
Chief Operating and BusinessOfficer
49 Since 2026
this year
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
2.4 years
from year joined
CEO also chairs the board
No
Scott Garland
Director Age On board Independent Other public boards 2025 pay Source
Scott Garland
57 Not stated Independent Enliven Therapeutics, Inc. $386,979
Heather Turner
53 2024
2 years
Not independent Terns Pharmaceuticals, Inc. Paid as CEO
Robert A. Lenz
55 2026
this year
Independent NovaBridge Biosciences Not stated
Rebecca Luse
41 2023
3 years
Independent None stated $248,036
Ran Nussbaum
53 2023
3 years
Independent None stated $246,512
Robert R. Ruffolo, Jr.
76 2019
7 years
Independent Elicio Therapeutics, Inc. Not stated
Rekha Hemrajani
56 2025
1 year
Independent ALX Oncology Holdings Inc., MaxCyte, Inc., BioAge Labs $252,913
William Kane
64 2025
1 year
Independent None stated $246,817

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support